{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:59:09Z","timestamp":1785358749777,"version":"3.55.0"},"reference-count":31,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>14-O-[(4,6-Diaminopyrimidine-2-yl)thioacetyl] mutilin (DPTM), a novel pleuromutilin candidate with a substituted pyrimidine moiety, has been confirmed to possess excellent antibacterial activity against Gram-positive bacteria. To illustrate the pharmacokinetic profile after intravenous (i.v.), intramuscular (i.m.) and oral (p.o.) administrations with DPTM, as well as tissue distribution and excretion via urine and feces in vivo, a specific, sensitive and robust HPLC-MS\/MS method was first developed to determine DPTM in rat plasma, various tissues, urine and feces. The plasma, tissues, urine and feces samples were treated by protein precipitation with acetonitrile using tiamulin fumarate as an internal standard (IS). This method which was achieved on an HPLC system detector equipped with an ESI interface, was sensitive with 5 ng\/mL as the lower limit of detection and exhibited good linearity (R2 &gt; 0.9900) in the range of 5\u20134000 ng\/mL for plasma, various tissues, urine and feces, as well as intra-day precision, inter-day precision and accuracy. The matrix effects ranged from 94.2 to 109.7% with RSD \u2264 9.4% and the mean extraction recoveries ranged from 95.4 to 109.5% in plasma, tissue homogenates, urine and feces (RSD \u2264 9.9). After i.v., i.m. and p.o. administrations, DPTM was rapidly absorbed and metabolized in rats with the half-life (t1\/2) of 1.70\u20131.86, 3.23\u20133.49 and 4.38\u20134.70 for 10, 25 and 75 mg\/kg doses, respectively. The tissue distribution showed that DPTM was diffused into all the tested tissues, especially into the intestine and lung. Excretion via urine and feces studies demonstrated that DPTM was mainly excreted by feces after administration.<\/jats:p>","DOI":"10.3390\/molecules24040790","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T03:49:44Z","timestamp":1550807384000},"page":"790","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Validated HPLC-MS\/MS Assay for 14-O-[(4,6-Diaminopyrimidine-2-yl)thioacetyl] Mutilin in Biological Samples and Its Pharmacokinetic, Distribution and Excretion via Urine and Feces in Rats"],"prefix":"10.3390","volume":"24","author":[{"given":"Yunxing","family":"Fu","sequence":"first","affiliation":[{"name":"Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Yi","sequence":"additional","affiliation":[{"name":"Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Liang","sequence":"additional","affiliation":[{"name":"Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruofeng","family":"Shang","sequence":"additional","affiliation":[{"name":"Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1073\/pnas.37.9.570","article-title":"Antibiotic substances from basidiomycetes: VIII. Pleurotus multilus (Fr.) sacc. and pleurotus passeckerianus pilat","volume":"37","author":"Kavanagh","year":"1951","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1021\/jacs.7b13260","article-title":"Total synthesis of (+)-pleuromutilin","volume":"140","author":"Farney","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.foodchem.2017.03.064","article-title":"Enhanced production of pleuromutilin by Pleurotus mutilus and study on its molecular structure","volume":"230","author":"Sun","year":"2017","journal-title":"Food Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1021\/acs.jmedchem.6b01805","article-title":"A New Combination of a Pleuromutilin Derivative and Doxycycline for Treatment of Multidrug-Resistant Acinetobacter baumannii","volume":"60","author":"Siricilla","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jiac.2013.12.009","article-title":"Influence of antimicrobial regimen on decreased in-hospital mortality of patients with MRSA bacteremia","volume":"20","author":"Kaku","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1046\/j.1365-2958.2001.02595.x","article-title":"The pleuromutilin drugs tiamulin and valnemulin bind to the RNA at the peptidyl transferase center on the ribosome","volume":"41","author":"Poulsen","year":"2001","journal-title":"Mol. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.2174\/15680266113136660217","article-title":"Efficient antibacterial agents: A review of the synthesis, biological evaluation and mechanism of pleuromutilin derivatives","volume":"13","author":"Shang","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_8","first-page":"182","article-title":"The pleuromutilin antibiotics: A new class for human use","volume":"11","author":"Novak","year":"2010","journal-title":"Curr. Opin. Invest. Drugs."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-2958.2004.04346.x","article-title":"Inhibition of peptide bond formation by pleuromutilins: The structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin","volume":"54","author":"Schlunzen","year":"2004","journal-title":"Mol. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1073\/pnas.0700041104","article-title":"Induced-fit tightens pleuromutilins, binding to ribosomes and remote interactions enable their selectivity","volume":"104","author":"Davidovich","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","first-page":"1","article-title":"Antibacterial properties and clinical potential of pleuromutilins","volume":"7","author":"Goethe","year":"2018","journal-title":"Nat. Prod. Rep."},{"key":"ref_12","first-page":"760","article-title":"Tiamulin activity against Brachyspira hyodysenteriae","volume":"163","author":"Burch","year":"2008","journal-title":"Vet. Rec."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.rvsc.2004.09.005","article-title":"The efficacy of valnemulin (Econor) in the control of disease caused by experimental infection of calves with Mycoplasma bovis","volume":"78","author":"Stipkovits","year":"2005","journal-title":"Res. Vet. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1128\/AAC.01678-17","article-title":"In vitro activities of miltefosine and antibacterial agents from the macrolide, oxazolidinone, and pleuromutilin classes against pythium insidiosum and pythium aphanidermatum","volume":"62","author":"Loreto","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/eri.09.7","article-title":"Microbiological profile of a new topical antibacterial: Retapamulin ointment 1%","volume":"7","author":"Shawar","year":"2009","journal-title":"Expert. Rev. Anti Infect. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1128\/AAC.01432-05","article-title":"Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci","volume":"50","author":"Jones","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1128\/AAC.02033-13","article-title":"Population Pharmacokinetic Analyses for BC-3781 Using Phase 2 Data from Patients with Acute Bacterial Skin and Skin Structure Infections","volume":"59","author":"Rubino","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cclet.2015.09.019","article-title":"Design, synthesis and antibacterial activity of novel pleuromutilin derivatives with 4H-pyran-4-one and pyridin-4-one substitution in the C-14 side chain","volume":"27","author":"Ling","year":"2016","journal-title":"Chin. Chem. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1128\/AAC.02008-16","article-title":"In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China","volume":"61","author":"Waites","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/jac\/dkv442","article-title":"Simultaneous assessment of the pharmacokinetics of a pleuromutilin, lefamulin, in plasma, soft tissues and pulmonary epithelial lining fluid","volume":"71","author":"Zeitlinger","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ejmech.2016.11.054","article-title":"Synthesis and antibacterial activities of novel pleuromutilin derivatives with a substituted pyrimidine moiety","volume":"126","author":"Yi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_22","first-page":"219","article-title":"Determination of 6258-70, a new semi-synthetic taxane, in rat plasma and tissues: Application to the pharmacokinetics and tissue distribution study","volume":"6","author":"Zhao","year":"2016","journal-title":"J. Pharmaceut. Anal."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/00071668.2012.703776","article-title":"Pharmacokinetics and bioavailability of valnemulin in muscovy ducks (cairina moschata)","volume":"53","author":"Sun","year":"2012","journal-title":"Brit. Poultry Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fvets.2016.00075","article-title":"Pharmacokinetic\/pharmacodynamic profiles of tiamulin in an experimental intratracheal infection model of Mycoplasma gallisepticum","volume":"3","author":"Xiao","year":"2016","journal-title":"Front. Vet. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/chromsci\/bmy033","article-title":"Determination of a new pleuromutilin derivative in broiler chicken plasma by RP-HPLC-UV and its application to a pharmacokinetic study","volume":"56","author":"Shang","year":"2018","journal-title":"J. Chromatogr. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1021\/jm500374c","article-title":"Synthesis and biological activities of novel pleuromutilin derivatives with a substituted thiadiazole moiety as potent drug-resistant bacteria inhibitors","volume":"57","author":"Shang","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.phrs.2017.11.010","article-title":"Antibacterial activity and pharmacokinetic profile of a promising antibacterial agent: 14-O-[(4-Amino-6-hydroxy-pyrimidine-2-yl)thioacetyl] mutilin","volume":"129","author":"Shang","year":"2018","journal-title":"Pharmacolog. Res."},{"key":"ref_28","unstructured":"European Medicines Agency (2015). Guideline on Bioanalytical Method Validation."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jpba.2016.09.003","article-title":"Pharmacokinetic properties, in vitro metabolism and plasma protein binding of govaniadine an alkaloid isolated from corydalis govaniana wall","volume":"131","author":"Marques","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jps.20327","article-title":"Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833","volume":"94","author":"Bostrom","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpba.2014.09.017","article-title":"A rapid and sensitive UPLC\u2013MS\/MS method for determination of HZ08 in rat plasma and tissues: Application to a pharmacokinetic study of liposome injections","volume":"102","author":"Yan","year":"2015","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/4\/790\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:34:00Z","timestamp":1760186040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/4\/790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["molecules24040790"],"URL":"https:\/\/doi.org\/10.3390\/molecules24040790","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]}}}